|
|
Article: Combination and collaboration: PharmaMedDevice assembles industry leaders in medical devices, pharmaceuticals and biologics to discuss the opportunities and challenges of combination products.(SHOW REVIEW: PharmaMedDevice)
- Article from:
- Medical Product Outsourcing
- Article date:
- March 1, 2008
CopyrightCOPYRIGHT 2008 Rodman Publishing. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Combination products--or perhaps you know them better as convergent technology. Call them what you will, drug-device combinations are one of the fastest-growing sectors in medical technology. Products such as inhalation devices, transdermal delivery systems, steroid-eluting electrodes and a range of biologic devices hold tremendous promise not only for patient care, but also as new untapped markets for medical device companies and their suppliers. With the global market for drug-device combinations expected to increase at an average annual growth rate of 13.6% and reach $11.5 billion by the end of the decade, there's plenty of room for optimism. But with opportunity comes ...